Vaxcyte, Inc. (PCVX)
58.13
-2.24
(-3.71%)
USD |
NASDAQ |
Sep 18, 16:00
58.14
0.00 (0.00%)
After-Hours: 20:00
Vaxcyte Max Drawdown (5Y) : 76.22% for Aug. 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| August 31, 2026 | 76.22% |
| July 31, 2026 | 76.22% |
| June 30, 2026 | 76.22% |
| May 31, 2026 | 76.22% |
| April 30, 2026 | 76.22% |
| March 31, 2026 | 76.22% |
| February 28, 2026 | 76.22% |
| January 31, 2026 | 76.22% |
| December 31, 2025 | 76.22% |
| November 30, 2025 | 76.22% |
| October 31, 2025 | 76.22% |
| September 30, 2025 | 76.22% |
| August 31, 2025 | 76.22% |
| July 31, 2025 | 76.22% |
| June 30, 2025 | 76.22% |
| May 31, 2025 | 76.22% |
| April 30, 2025 | 76.22% |
| March 31, 2025 | 70.31% |
| February 28, 2025 | 70.31% |
| January 31, 2025 | 70.31% |
| December 31, 2024 | 70.31% |
| November 30, 2024 | 70.31% |
| October 31, 2024 | 70.31% |
| September 30, 2024 | 70.31% |
| August 31, 2024 | 70.31% |
| Date | Value |
|---|---|
| July 31, 2024 | 70.31% |
| June 30, 2024 | 70.31% |
| May 31, 2024 | 70.31% |
| April 30, 2024 | 70.31% |
| March 31, 2024 | 70.31% |
| February 29, 2024 | 70.31% |
| January 31, 2024 | 70.31% |
| December 31, 2023 | 70.31% |
| November 30, 2023 | 70.31% |
| October 31, 2023 | 70.31% |
| September 30, 2023 | 70.31% |
| August 31, 2023 | 70.31% |
| July 31, 2023 | 70.31% |
| June 30, 2023 | 70.31% |
| May 31, 2023 | 70.31% |
| April 30, 2023 | 70.31% |
| March 31, 2023 | 70.31% |
| February 28, 2023 | 70.31% |
| January 31, 2023 | 70.31% |
| December 31, 2022 | 70.31% |
| November 30, 2022 | 70.31% |
| October 31, 2022 | 70.31% |
| September 30, 2022 | 70.31% |
| August 31, 2022 | 70.31% |
| July 31, 2022 | 70.31% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Moderna, Inc. | 95.38% |
| Arrowhead Pharmaceuticals, Inc. | 88.96% |
| Oncolytics Biotech, Inc. | 92.83% |
| Sangamo Therapeutics, Inc. | 99.68% |
| Sarepta Therapeutics, Inc. | 93.33% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 3.509 |
| Beta (5Y) | 1.219 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 66.35% |
| Historical Sharpe Ratio (5Y) | 0.2196 |
| Historical Sortino (5Y) | 0.3879 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 19.97% |